Parabilis Medicines, Inc. (NASDAQ:PBLS - Free Report) - Stock analysts at HC Wainwright reduced their FY2026 earnings per share (EPS) estimates for shares of Parabilis Medicines in a report issued on Friday, November 13th. HC Wainwright analyst R. Burns now forecasts that the company will post earni...